Republican presidential candidate Jeb Bush on Tuesday will lay out proposals to repeal President Barack Obama's health-care law and replace it.» Read More
Figuring out how much to save for future health-care costs is one of the toughest parts of retirement planning. Here's what you should know.
Johnson & Johnson will become the first pharmaceutical company to formally seek advice from outside medical ethicists on "compassionate use" requests.
Employment health plans were the big engine for covering people after Obamacare launched, with 9.6 million newly insured.
In a world where you can order what you want at a click of a button; shouldn't technology help you watch what you eat?
Unless Europe’s governments take action, it will be dealing with an obesity epidemic of vast proportions by 2030, according to new projections.
Alexion said it would buy Synageva for $8.4 billion to gain access to its experimental early-stage treatment for a rare metabolic disease.
One of the U.K's most prominent fund managers has joined Bill Gates in backing a small biopharmaceutical firm with a bumper $50 million investment.
The U.S. government said health insurers must cover all FDA-approved methods of birth control without co-pays or charges to the patient.
GlaxoSmithKline laid out growth targets for biggest businesses on Wednesday, hoping to convince investors that it would return to long-term growth.
The Obamacare insurance market could become less stable if a program designed to limit insurers' risk isn't fully funded.
That's up more than 10 percent from 2013 and up from $75 billion five years earlier, according to a new report.
Microsoft co-founder and philanthropist Bill Gates believes profits should not always be the sole motivating factor.
Medicare booked more than $384 million in savings from an Obamacare program designed to lower the costs of treating beneficiaries.
With the 2016 election looming, big issues weigh on small businesses including the minimum wage, health-care costs, taxes and the credit markets.
Jon Najarian, co-founder of OptionMonster.com, breaks down a worrisome trend in the stock market right now.
Traders are watching the iShares Nasdaq Biotechnology ETF for clues on whether a deeper stock market decline is on the horizon.
Ever wonder why it’s often so hard to find a doctor, especially if you don’t live in a big city?
As biotech has boomed over the last few years, so has real estate in Kendall Square in Cambridge, Massachusetts.
When Dale Messenger was paralyzed following a gunshot wound he thought he wouldn't walk again. But now he is, with the help of a wearable bionic suit.
The robots are pricy, but this hospital hopes to save labor costs.
Get the best of CNBC in your inbox